Identification of osimertinib resistance mechanisms in Chinese NSCLC patients: Analysis from AURA17 trial.

Min Hu; Yi‐Long Wu; Xuehua Zhu; Yun Sun; Xuesong Lu; Jia Wang; Mengzhao Wang; Ying Cheng; Yuan Chen; Yanqiu Zhao

doi:10.1200/jco.2018.36.15_suppl.9077

Identification of osimertinib resistance mechanisms in Chinese NSCLC patients: Analysis from AURA17 trial.

Identifier:nobleid.org/w1/20260515/2EAAC00D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2EAAC00D.svg?ark=w1%2F20260515%2F2EAAC00D)](https://nobleid.org/work/w1/20260515/2EAAC00D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Identification of osimertinib resistance mechanisms in Chinese NSCLC patients: Analysis from AURA17 trial.

Identifier:nobleid.org/w1/20260515/2EAAC00D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2EAAC00D.svg?ark=w1%2F20260515%2F2EAAC00D)](https://nobleid.org/work/w1/20260515/2EAAC00D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work